knowledge -WSS

knowledge

author：knowledge 2025-08-26 23:46:25 - browse：15429

Sage Therapeutics, a biotech developing an experimental treatment for postpartum depression, this week trumpeted strong results from a clinical trial, which cheered investors and pushed up its stock price. But outside the lab, the company’s aggressive efforts to raise awareness of postpartum depression have proved divisive.

The campaign’s message: “When it comes to postpartum depression, silence sucks.” It features close-up photos of distressed, tearful women who can’t speak — because they have pacifiers stuck in their mouths.

The images have been plastered on bus stops, buses, conference booths, and on a dedicated website. The ads don’t specifically mention Sage’s drug, which still needs further testing before the company can bring it to the Food and Drug Administration for possible approval. Instead, they urge women to talk “openly and honestly” about postpartum depression. An estimated 600,000 women in the U.S. alone experience symptoms, which range from insomnia and irritability to difficulty bonding with their baby.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： How to save PrEP access — and even expand it

leisure time

WSS

Can sheer will power keep patients alive in their dying hours?

Violet CEO on training clinicians to promote more inclusive care

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Grail spinoff by Illumina should end disastrous merger attempt

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

Wikipedia

knowledge

knowledge

Drug repurposing or repositioning? The language matters

Cancer drug shortages should be causing more outrage

After affirmative action ruling, medical educators look to 'holistic review'

Activists slam private health insurers over coverage restrictions

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Medicare Advantage beneficiaries sue Humana over algorithm use

Heart attack and stroke risk calculators need revising

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Heart attack and stroke risk calculators need revising

Virginia high school admissions case could be legal follow

hotspot

Supreme Court strikes down use of affirmative action

Hollywood unions extend contract negotiations for actors

Medical records are filled with copy

In age of alternative facts, a scholarly course on calling out crap

In age of alternative facts, a scholarly course on calling out crap

Affirmative action in medical school literally saved lives

explore

leisure time

knowledge

knowledge